Home Must Read Articles

Must Read Articles

After the Cancer Diagnosis: Six Steps for Moving from Fear to Action

A diagnosis of cancer triggers distress, uncertainty and fear – all of which creates the need for many important conversations with the patient, physician, family and care providers. The key to dealing with these emotional reactions is to work through a series of six steps that will help the patient to overcome the paralysis they can cause and move...

Killing Cancer Cells by Shining a Light on a Rare Metal

Iridium –  a very hard, brittle, second-densest silvery-white transition metal of the platinum group, is a found in meteorites in a much higher abundance than in the Earth's crust. As a result, the unusually high abundance of iridium in the clay layer at the Cretaceous–Paleogene boundary resulted in the Alvarez hypothesis, which suggest that the impact of a massive extraterrestrial...

Colorectal Cancer Screening Helps Avoids Intense Treatments in Men

Colorectal cancer (CRC) is the third most common form of cancer in the world. In Finland, a country with approximately 5.5 million people (compare the United States population in 2017 was 325.70 million), approximately 3,000 new patient cases are diagnosed every year, and roughly 1,200 patients die of the disease. Between 2004 and 2016, an extensive screening program was conducted in...

National Cancer Institute Awards $16 million Grant to Establish a Cancer Health Equity Center

The National Cancer Institute (NCI) has awarded a five-year, U.S. $ 16 million grant to establish a cancer health equity center at the University of Florida and partner institutions, inducing, Florida A&M University and the University of Southern California. Combined, Florida and California have the highest cancer incidence and mortality in the United States and the new center is designed...

Examining Cost and Benefit: Quality Care in Cancer is Not Only a Matter of Proper Medication

The European Society of Medical Oncology, ESMO, the leading professional organization for medical oncology with over 18,000 members representing oncology professionals from over 150 countries worldwide, this week, shared concerns expressed in a scientific paper discussing the rising costs of cancer medicines. The purpose of the study was to determine if clinical benefits of novel anticancer drugs, measured by the...

Immunotherapy’s Promise for Lung Cancer Treatment

Cancer research is often defined by slow, incremental progress, building upon years, often decades, of previous discoveries. Then if we get lucky, someone figures out something that adds jet fuel to the process, propelling the entire field forward with new energy and new optimism. As chief of oncology at Yale and having cared for lung cancer patients for the...

Mike Caligiuri Discusses Upcoming AACR Meeting, Cancer Health Equality, and Sudden Career Change

During last year’s American Association for Cancer Research (AACR) annual meeting in Washington, DC, the association’s president Michael A. Caligiuri, MD, discussed his presidential initiative to further cancer health equality. He said this would include: reducing health disparities; recruiting, retaining, and promoting clinical researchers and scientists from underserved populations; and communicating effectively with survivors and patients about strategies to further...

Three Pillars of Psycho-social Support for Children of a Parent with Cancer

“Life without a mother – how would that be? A year in which we would all define what love really meant, how tight our family really was, and soon after… how easily everything could fall apart. It was going to be the year I had to start taking care of myself, and grow into maturity – even though I...

Why Academia Wasn’t Ready to Build Big Data Systems – A Conversation with Amy Abernethy

Big news hit the pharmaceutical industry in February when Roche Pharmaceuticals announced that it would be acquiring big-data firm Flatiron Health for $1.9 billion. Roche already held a 12% stake in Flatiron, so the total value of the deal--which was completed in early April--will be $2.1 billion, and under the agreement Flatiron would continue its operations as a separate legal...

Survivin – Creating New Opportunities for CAR T and Antibody-based Therapies

New research from Roswell Park Comprehensive Cancer Center and MimiVax, a clinical-stage pharmaceutical company focused on the development and commercialization of immunotherapeutics and targeted therapies for cancer treatment, which was, in part, funded by the American Cancer Society, Philip H. Hubbell, the Linda Scime Endowment, the National Cancer Institute, shows that one of the most commonly occurring molecules in cancer...

right side

ads

Related articles